5-APDI

From Wikipedia, the free encyclopedia
Indanylaminopropane
Systematic (IUPAC) name
(±)-1-(2,3-dihydro-1H-inden-5-yl)propan-2-amine
Clinical data
Legal status Uncontrolled (but may be covered under the Federal Analogue Act in the United States and under similar bills in other countries)
Routes Oral
Identifiers
CAS number 152624-02-7 YesY
ATC code None
PubChem CID 192600
ChemSpider 167142 YesY
ChEMBL CHEMBL6842 YesY
Synonyms 1-(5-indanyl)-2-aminopropane
Chemical data
Formula C12H17N 
Mol. mass 175.27 g/mol
 YesY (what is this?)  (verify)

5-(2-Aminopropyl)-2,3-dihydro-1H-indene (5-APDI), also known as indanylaminopropane (IAP), IAP (psychedelic), 2-API(2-aminopropylindane), indanametamine, and, incorrectly, as indanylamphetamine,[1] is an entactogen and psychedelic drug of the amphetamine family.[2][3] It has been sold by online vendors through the Internet and has been encountered as a designer drug since 2003,[1][4][5] but its popularity has diminished in recent years.

5-APDI acts as a potent and weakly selective serotonin releasing agent (SSRA) with IC50 values of 82 nM, 1,848 nM, and 849 nM for inhibiting the reuptake of serotonin, dopamine, and norepinephrine, respectively.[2][3] It fully substitutes for MBDB but not amphetamine in trained animals, though it does produce disruption for the latter at high doses.[2]

Anecdotal reports suggest that 5-APDI is considerably less stimulating and euphoric than related compounds like MDMA.[4][5] However, in combination with amphetamine, DMAA, or a low dose of 2C-I, it is said to be virtually indistinguishable from MDA by recreational users.[4][5]

See also

References

  1. ↑ 1.0 1.1 Casale JF, McKibben TD, Bozenko JS, Hays PA (2005). "Characterization of the "Indanylamphetamines"". Microgram Journal 3 (1–2): 3–10. 
  2. ↑ 2.0 2.1 2.2 Monte AP, Marona-Lewicka D, Cozzi NV, Nichols DE (November 1993). "Synthesis and pharmacological examination of benzofuran, indan, and tetralin analogues of 3,4-(methylenedioxy)amphetamine". Journal of Medicinal Chemistry 36 (23): 3700–6. doi:10.1021/jm00075a027. PMID 8246240. 
  3. ↑ 3.0 3.1 Parker MA, Marona-Lewicka D, Kurrasch D, Shulgin AT, Nichols DE (March 1998). "Synthesis and pharmacological evaluation of ring-methylated derivatives of 3,4-(methylenedioxy)amphetamine (MDA)". Journal of Medicinal Chemistry 41 (6): 1001–5. doi:10.1021/jm9705925. PMID 9526575. 
  4. ↑ 4.0 4.1 4.2 "Bluelight Forums - The Big and Dandy Indanylaminopropane (IAP) Thread". 
  5. ↑ 5.0 5.1 5.2 "Erowid Experience Vaults - Indanylaminopropane (IAP)". 

External links

Phenylalkylamines
Cyclized phenyl-
alkylamines
Tryptamines
Others
Psychedelics
5-HT2AR agonists
Others
Dissociatives
NMDAR antagonists
Others
Deliriants
mAChR antagonists
Miscellaneous
Others

Phenethylamines
Amphetamines
Phentermines
Cathinones
Phenylisobutylamines
Phenylalkylpyrrolidines
Catecholamines
(and close relatives)
Miscellaneous
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.